Should pituitary carcinoma be treated using a NET-like approach? A case of complete remission of a metastatic malignant prolactinoma with multimodal therapy including immunotherapy

Clin Endocrinol (Oxf). 2023 Apr;98(4):633-637. doi: 10.1111/cen.14645. Epub 2021 Nov 29.

¹ Department of Internal Medicine and Endocrinology, Hôpital de Hautepierre, Hôpitaux Universitaires, Strasbourg, France.
² Department of Radiology, Hôpital de Hautepierre, Hôpitaux Universitaires, Strasbourg, France.
³ Department of Medical Oncology, Institut de Cancérologie de Strasbourg Europe (ICANS), Strasbourg, France.
⁴ Department of de Radiotherapy, Institut de Cancérologie de Strasbourg Europe (ICANS), Strasbourg, France.
⁵ Department of Nuclear Medicine and Molecular Imaging, Institut de Cancérologie de Strasbourg Europe (ICANS), Strasbourg, France.

No abstract available

Keywords: conditions; investigations & RXT; pituitary; pituitary irradiation; pituitary macroadenoma; prolactinoma.

Publication types